Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
15/05/2025
HC Wainwright & Co.: Assumes a Buy rating on Humacyte (HUMA.US) with a target price of $4.00.
Latest
2 m ago
The first batch of CSI Free Cash Flow ETFs are gradually listing. On May 13th, two public fund institutions, CMB Fund Management Co., Ltd. and ICBC Credit Suisse Fund Management Co., Ltd., announced that their CSI Free Cash Flow ETFs will be listed on May 16th. The free cash flow strategy is receiving more and more attention from the market. According to industry insiders, companies selected by the free cash flow strategy usually have strong risk resistance and stable operating performance, showing relatively stable performance in market fluctuations. With the encouragement and promotion from regulatory authorities, companies will pay more attention to the quality of their own free cash flow and the improvement of free cash flow returns. Investors' demand for assets with good cash flow performance is expected to continue to increase. (Securities Daily)
2 m ago
Free cash flow strategy attracts attention as public funds continue to allocate resources.
2 m ago
Risky capital "multi-pronged approach" increases market entry efforts, expected to increase allocation of components of the CSI A500 index.
3 m ago
Nine banks' first phase of Sci-Tech Innovation Bonds will have a total issuance size of 120 billion yuan.
3 m ago
Banking institutions continue to issue technology innovation bonds, and bond funds are flowing rapidly into technology innovation enterprises. On May 16, Shanghai Bank will issue the first tranche of technology innovation bonds due in 2025 with a scale of 5 billion yuan. According to public information from China Money, as of May 14, nine banks have issued announcements related to the first tranche of 2025 technology innovation bonds, with eight banks having completed their issuances, including the China Development Bank, Industrial and Commercial Bank of China, Agricultural Bank of China, Bank of Communications, Industrial Bank, Shanghai Pudong Development Bank, Hangzhou Bank, and Bohai Bank. The total issuance scale of technology innovation bonds from the nine banks mentioned above will reach 120 billion yuan. Several banks have stated that the funds raised will be accurately directed towards the field of technology innovation, providing financial support for the growth and development of technology innovation enterprises. (Securities Daily)
See all latest
